Inducing the combined deletion of phosphatase and tensin homolog (PTEN), tumor protein p53 (TP53), and retinoblastoma 1 (RB1) in mouse astrocytes can lead to the malignant progression of glioma, manifested as a transition from WHO grade III to WHO grade IV [40]. The gene discussed is PTEN; the disease is central nervous system cancer.